Entry Point Capital, LLC Adma Biologics, Inc. Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 18,331 shares of ADMA stock, worth $319,875. This represents 0.21% of its overall portfolio holdings.
Number of Shares
18,331
Previous 6,433
184.95%
Holding current value
$319,875
Previous $71.9 Million
99.49%
% of portfolio
0.21%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$325 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$316 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$227 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$220 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$150 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.43B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...